Effects of combine training on Serum Adropin and nitric oxide in stage-1 hypertensive postmenopausal women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180430039485N1

Enrollment

Registered

2018-07-13

Start date

2018-05-20

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hypertention. Condition 2: Hypertension. Hypertensive heart disease Hypertensive heart disease with heart failure

Interventions

Intervention 1: Intervention group: combine training. Intervention 2: Control group: normal life style withouth any changes.

Eligibility

Sex/Gender

Female

Age

50 Years to 65 Years

Inclusion criteria

Inclusion criteria: Systolic and diastolic blood pressure >140/90 and<159/99 Menopausal women No any participant to regular exercise training for 1 year

Exclusion criteria

Exclusion criteria: Functional limitations (such as osteoarthritis) Systolic blood pressure more than 160 and diastolic more than 100 mm Hg Body mass index >28 Diabetes and obesity Cardiovascular disease Liver and kidney disease mental disease Cessation of drug use during the study No use hormone therapy, no smoking and no use alcohol

Design outcomes

Primary

Measure	Time frame
Serum adropin level. Timepoint: pre study and after 8 weeks. Method of measurement: adropin kit.;Serum nitric oxide level. Timepoint: pre study and after 8 weeks. Method of measurement: nitric oxide kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoudabeh Sharabiani

Kharazmi University

sharabiany2006@gmail.com+98 443563903

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026